Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Anteris Technologies Global Corp.AVR · Entity 5089 | Director | June 07, 2026 | June 10, 2026 |
| LEMAITRE VASCULAR INCLMAT · Entity 1927 | Director · President and Director | September 03, 2026 | September 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Anteris Technologies Global Corp.
Report date June 07, 2026 · Filed June 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,580 |
Reported balance
After 2026-06-07 transaction · row 1
1 source rowRow 1 · 2026-06-07 · Exercise / conversion · Acquired 17,580 · Balance 17,580 F1: Each restricted stock unit ("RSU") converts into a share of common stock on a one-for-one basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 35,162 |
Reported balance
After 2026-06-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-07 · Exercise / conversion · Disposed 17,580 · Balance 35,162 F1: Each restricted stock unit ("RSU") converts into a share of common stock on a one-for-one basis. F2: On December 3, 2025, the reporting person was granted 52,742 RSUs that generally vest in approximately equal installments on June 7, 2026, June 7, 2027 and June 7, 2028, subject to the Reporting Person's continued service through each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") converts into a share of common stock on a one-for-one basis.
F2: On December 3, 2025, the reporting person was granted 52,742 RSUs that generally vest in approximately equal installments on June 7, 2026, June 7, 2027 and June 7, 2028, subject to the Reporting Person's continued service through each vesting date.
LEMAITRE VASCULAR INC
Report date September 03, 2026 · Filed September 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 25.4682 |
Reported balance
After 2026-09-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-03 · Grant · Acquired 2.1262 · Balance 25.4682 F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 24.7852 |
Reported balance
After 2026-09-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-03 · Grant · Acquired 2.1262 · Balance 24.7852 F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 30.34 |
Reported balance
After 2026-09-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-03 · Grant · Acquired 3.6322 · Balance 30.34 F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 32.3815 |
Reported balance
After 2026-09-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-09-03 · Grant · Acquired 4.3524 · Balance 32.3815 F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 17.5403 |
Reported balance
After 2026-09-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-03 · Grant · Acquired 3.1566 · Balance 17.5403 F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 18.6239 |
Reported balance
After 2026-09-03 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-09-03 · Grant · Acquired 3.5757 · Balance 18.6239 F6: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 1.9861 |
Reported balance
After 2026-09-03 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-09-03 · Grant · Acquired 0.3056 · Balance 1.9861 F7: These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 2.0893 |
Reported balance
After 2026-09-03 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-09-03 · Grant · Acquired 0.3453 · Balance 2.0893 F8: These dividend equivalent rights accrued on a performance share unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 13.6627 |
Reported balance
After 2026-09-03 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-09-03 · Grant · Acquired 5.2874 · Balance 13.6627 F9: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F6: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F7: These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F8: These dividend equivalent rights accrued on a performance share unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F9: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 03, 2018 Filed Aug 6, 2018 20:06 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 9,752 | $0.00 Strike: $11.43 | $0.00 |
DisclosureSEC source: 0001209191-18-045506 · doc4.xml · derivative · entry 6 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,503 Underlying: Common Stock · 9,752 shares Expires 2022-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vesting in equal annual installments over the remaining four years. Read SEC document |
| August 03, 2018 Filed Aug 6, 2018 20:06 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,575 | $0.00 Strike: $7.87 | $0.00 |
DisclosureSEC source: 0001209191-18-045506 · doc4.xml · derivative · entry 5 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,574 Underlying: Common Stock · 8,575 shares Expires 2021-07-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vesting in equal annual installments over the remaining four years. Read SEC document |
| August 03, 2018 Filed Aug 6, 2018 20:06 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 10,009 | $14.13 | $141,427.17 |
DisclosureSEC source: 0001209191-18-045506 · doc4.xml · nonDerivative · entry 4 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,709 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| August 03, 2018 Filed Aug 6, 2018 20:06 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 9,752 | $11.43 | $111,465.36 |
DisclosureSEC source: 0001209191-18-045506 · doc4.xml · nonDerivative · entry 3 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| August 03, 2018 Filed Aug 6, 2018 20:06 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 8,575 | $7.87 | $67,485.25 |
DisclosureSEC source: 0001209191-18-045506 · doc4.xml · nonDerivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,948 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| August 02, 2018 Filed Aug 6, 2018 20:06 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 21,005 | $35.72 | $750,302.80 |
DisclosureSEC source: 0001209191-18-045506 · doc4.xml · nonDerivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,373 F1 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $35.50 to $35.96. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| July 25, 2018 Filed Jul 27, 2018 23:10 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 10 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-044271 · doc4.xml · derivative · entry 3 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42 Underlying: Common Stock · 10 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 7/25/2016. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 7/25/2016. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 7/25/2016. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 7/25/2016. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| July 25, 2018 Filed Jul 27, 2018 23:10 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 264 | $37.36 | $9,863.04 |
DisclosureSEC source: 0001209191-18-044271 · doc4.xml · nonDerivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,378 F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on July 25, 2016. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| July 25, 2018 Filed Jul 27, 2018 23:10 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 10 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-044271 · doc4.xml · nonDerivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,642 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| June 07, 2018 Filed Jun 8, 2018 20:21 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 4 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-036676 · doc4.xml · derivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7 Underlying: Common Stock · 4 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 07, 2018 Filed Jun 8, 2018 20:21 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 7 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-036676 · doc4.xml · derivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52 Underlying: Common Stock · 7 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:25 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 153 | $32.72 | $5,006.16 |
DisclosureSEC source: 0001209191-18-027633 · doc4.xml · nonDerivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,632 Read SEC document |
| April 05, 2018 Filed Apr 9, 2018 20:22 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-024328 · doc4.xml · derivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3 Underlying: Common Stock · 3 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| April 05, 2018 Filed Apr 9, 2018 20:22 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 6 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-024328 · doc4.xml · derivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45 Underlying: Common Stock · 6 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 22, 2017 Filed Dec 28, 2017 01:39 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantStock Option (Right to Buy) · Derivative | 17,303 | $0.00 Strike: $31.30 | $0.00 |
DisclosureSEC source: 0001209191-17-067474 · doc4.xml · derivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,303 Underlying: Common Stock · 17,303 shares Expires 2024-12-22 F2 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years. Read SEC document |
| December 22, 2017 Filed Dec 28, 2017 01:39 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 1,997 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-067474 · doc4.xml · nonDerivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,479 F1 · shares: Represents a restricted stock unit award that vests on a time-based schedule as follows: 20% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining four years. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date. Read SEC document |
| December 07, 2017 Filed Dec 11, 2017 21:31 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 6 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-065001 · doc4.xml · derivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39 Underlying: Common Stock · 6 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| November 06, 2017 Filed Nov 7, 2017 22:44 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 4,123 | $32.14 | $132,528.06 |
DisclosureSEC source: 0001209191-17-059643 · doc4.xml · nonDerivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,482 F1 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $32.10 to $32.21. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| September 07, 2017 Filed Sep 11, 2017 20:53 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 5 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-052250 · doc4.xml · derivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33 Underlying: Common Stock · 5 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| August 30, 2017 Filed Sep 2, 2017 00:23 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,180 | $0.00 Strike: $14.13 | $0.00 |
DisclosureSEC source: 0001209191-17-051110 · doc4.xml · derivative · entry 5 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,796 Underlying: Common Stock · 7,180 shares Expires 2023-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vesting in equal annual installments over the remaining four years. Read SEC document |
| August 30, 2017 Filed Sep 2, 2017 00:23 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 19,503 | $0.00 Strike: $11.43 | $0.00 |
DisclosureSEC source: 0001209191-17-051110 · doc4.xml · derivative · entry 4 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,255 Underlying: Common Stock · 19,503 shares Expires 2022-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vesting in equal annual installments over the remaining four years. Read SEC document |
| August 30, 2017 Filed Sep 2, 2017 00:23 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 26,683 | $36.67 | $978,478.95 |
DisclosureSEC source: 0001209191-17-051110 · doc4.xml · nonDerivative · entry 3 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,605 F2 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $36.52 to $37.17. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| August 30, 2017 Filed Sep 2, 2017 00:23 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 7,180 | $14.13 | $101,453.40 |
DisclosureSEC source: 0001209191-17-051110 · doc4.xml · nonDerivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,288 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| August 30, 2017 Filed Sep 2, 2017 00:23 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 19,503 | $11.43 | $222,919.29 |
DisclosureSEC source: 0001209191-17-051110 · doc4.xml · nonDerivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,108 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| August 04, 2017 Filed Aug 8, 2017 21:32 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 25,723 | $0.00 Strike: $7.87 | $0.00 |
DisclosureSEC source: 0001209191-17-048136 · doc4.xml · derivative · entry 7 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,149 Underlying: Common Stock · 25,723 shares Expires 2021-07-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vesting in equal annual installments over the remaining four years. Read SEC document |
| August 04, 2017 Filed Aug 8, 2017 21:32 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 21,094 | $0.00 Strike: $7.10 | $0.00 |
DisclosureSEC source: 0001209191-17-048136 · doc4.xml · derivative · entry 6 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,094 shares Expires 2018-07-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| August 04, 2017 Filed Aug 8, 2017 21:32 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,500 | $0.00 Strike: $6.51 | $0.00 |
DisclosureSEC source: 0001209191-17-048136 · doc4.xml · derivative · entry 5 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2018-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| August 04, 2017 Filed Aug 8, 2017 21:32 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 48,317 | $33.12 | $1,600,283.20 |
DisclosureSEC source: 0001209191-17-048136 · doc4.xml · nonDerivative · entry 4 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,605 F2 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $32.70 to $33.54. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| August 04, 2017 Filed Aug 8, 2017 21:32 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 25,723 | $7.87 | $202,440.01 |
DisclosureSEC source: 0001209191-17-048136 · doc4.xml · nonDerivative · entry 3 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,922 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| August 04, 2017 Filed Aug 8, 2017 21:32 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 21,094 | $7.10 | $149,767.40 |
DisclosureSEC source: 0001209191-17-048136 · doc4.xml · nonDerivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,199 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| August 04, 2017 Filed Aug 8, 2017 21:32 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 1,500 | $6.51 | $9,765.00 |
DisclosureSEC source: 0001209191-17-048136 · doc4.xml · nonDerivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,105 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| July 25, 2017 Filed Jul 28, 2017 01:35 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 5 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-046504 · doc4.xml · derivative · entry 3 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28 Underlying: Common Stock · 5 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 7/25/2016. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 7/25/2016. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 7/25/2016. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 7/25/2016. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| July 25, 2017 Filed Jul 28, 2017 01:35 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 419 | $28.58 | $11,975.02 |
DisclosureSEC source: 0001209191-17-046504 · doc4.xml · nonDerivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,605 F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on July 25, 2016. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| July 25, 2017 Filed Jul 28, 2017 01:35 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 5 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-046504 · doc4.xml · nonDerivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,024 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| June 08, 2017 Filed Jun 12, 2017 20:46 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 7 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-039189 · doc4.xml · derivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33 Underlying: Common Stock · 7 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 05, 2017 Filed Jun 7, 2017 20:02 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 20,105 | $0.00 Strike: $7.10 | $0.00 |
DisclosureSEC source: 0001209191-17-038271 · doc4.xml · derivative · entry 4 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,094 Underlying: Common Stock · 20,105 shares Expires 2018-07-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| June 05, 2017 Filed Jun 7, 2017 20:02 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,500 | $0.00 Strike: $6.50 | $0.00 |
DisclosureSEC source: 0001209191-17-038271 · doc4.xml · derivative · entry 3 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2017-11-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| June 05, 2017 Filed Jun 7, 2017 20:02 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 20,105 | $7.10 | $142,745.50 |
DisclosureSEC source: 0001209191-17-038271 · doc4.xml · nonDerivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,019 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| June 05, 2017 Filed Jun 7, 2017 20:02 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 1,500 | $6.50 | $9,750.00 |
DisclosureSEC source: 0001209191-17-038271 · doc4.xml · nonDerivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,914 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| May 11, 2017 Filed May 12, 2017 20:09 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 39,531 | $30.37 | $1,200,679.02 |
DisclosureSEC source: 0001209191-17-031895 · doc4.xml · nonDerivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,414 F1 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $30.00 to $31.10. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| May 04, 2017 Filed May 5, 2017 20:02 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 22,980 | $0.00 Strike: $5.85 | $0.00 |
DisclosureSEC source: 0001209191-17-030278 · doc4.xml · derivative · entry 4 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,980 shares Expires 2017-07-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| May 04, 2017 Filed May 5, 2017 20:02 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 22,980 | $31.20 | $717,005.87 |
DisclosureSEC source: 0001209191-17-030278 · doc4.xml · nonDerivative · entry 3 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,945 F3 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $30.54 to $31.72. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| May 04, 2017 Filed May 5, 2017 20:02 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 22,980 | $5.85 | $134,433.00 |
DisclosureSEC source: 0001209191-17-030278 · doc4.xml · nonDerivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,925 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| May 03, 2017 Filed May 5, 2017 20:02 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 21,360 | $31.07 | $663,595.39 |
DisclosureSEC source: 0001209191-17-030278 · doc4.xml · nonDerivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,945 F1 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $30.33 to $32.53. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| April 25, 2017 Filed Apr 26, 2017 20:39 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 21,360 | $0.00 Strike: $5.85 | $0.00 |
DisclosureSEC source: 0001209191-17-028215 · doc4.xml · derivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,980 Underlying: Common Stock · 21,360 shares Expires 2017-07-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| April 25, 2017 Filed Apr 26, 2017 20:39 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 21,360 | $5.85 | $124,956.00 |
DisclosureSEC source: 0001209191-17-028215 · doc4.xml · nonDerivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,305 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| April 06, 2017 Filed Apr 7, 2017 20:52 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 9 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-026296 · doc4.xml · derivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26 Underlying: Common Stock · 9 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 10, 2017 Filed Mar 10, 2017 21:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 5,900 | $22.44 | $132,380.07 |
DisclosureSEC source: 0001209191-17-019835 · doc4.xml · nonDerivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,945 F1 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $22.23 to $22.61. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| December 05, 2016 Filed Dec 7, 2016 21:16 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 8 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-153886 · doc4.xml · derivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17 Underlying: Common Stock · 8 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| November 17, 2016 Filed Nov 21, 2016 21:53 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 20,000 | $24.64 | $492,890.00 |
DisclosureSEC source: 0001209191-16-151464 · doc4.xml · nonDerivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,845 F1 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $23.76 to $24.99. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.